B22 - Radium-223 in metastatic castration-resistant prostate cancer (mCRPC): efficacy and safety in real-life experience
| Autor: | Rebuzzi, S.E., Prelaj, A., Pozzi, C., Ferrara, C., Frantellizzi, V., Follacchio, G.A., de Vincentis, G., Tomao, S., Bianco, V. |
|---|---|
| Zdroj: | In Annals of Oncology October 2017 28 Supplement 6:vi23-vi24 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|